A detailed history of Rhenman & Partners Asset Management Ab transactions in Bruker Corp stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 44,315 shares of BRKR stock, worth $2.58 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
44,315
Previous 6,000 638.58%
Holding current value
$2.58 Million
Previous $382,000 701.05%
% of portfolio
0.25%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$60.3 - $70.67 $2.31 Million - $2.71 Million
38,315 Added 638.58%
44,315 $3.06 Million
Q2 2024

Aug 13, 2024

SELL
$63.57 - $92.93 $889,980 - $1.3 Million
-14,000 Reduced 70.0%
6,000 $382,000
Q1 2024

May 14, 2024

BUY
$69.21 - $94.27 $276,840 - $377,080
4,000 Added 25.0%
20,000 $1.88 Million
Q4 2023

Feb 13, 2024

BUY
$54.91 - $74.64 $878,560 - $1.19 Million
16,000 New
16,000 $1.18 Million

Others Institutions Holding BRKR

About BRUKER CORP


  • Ticker BRKR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 148,138,000
  • Market Cap $8.61B
  • Description
  • Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...
More about BRKR
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.